SEARCH VEGSOURCE:

 

 

Follow Ups | Post Followup | Back to Discussion Board | VegSource
See spam or
inappropriate posts?
Please let us know.
  




From: TSS ()
Subject: Vacci-Text Corp. announce "LIVE" DIAGNOSTIC TEST FOR BSE
Date: June 18, 2005 at 7:37 pm PST

June 16:

Vacci-Test Corporation today announced that a simple, reliable and economical diagnostic tool for the detection in ''live'' cattle of infectious Brain Diseases (''BD''), including Bovine Spongiform Encephalopathy (BSE), will soon be available for use on farms and ranches in Canada and around the world.

______

June 15:

Vacci-Test is presenting the world's first live cattle test for BSE on June 16th. It is scheduled to take place at 1:00pm in the Royal Room, Metropolitan Conference Centre 333-4th Avenue S.W., Calgary, Alberta, Canada.

As a result of its successful laboratory testing program, the Corporation will have a simple, reliable and inexpensive live animal test for BSE known as Vacci-Test BD, which will be available soon for use on farms and ranches in Canada and around the world. ''We have proof that we can identify the BSE marker in the blood'' says Vacci-Test Chief Scientific Officer Dr. Jacques A. Mayet.

''Vacci-Test BD will facilitate affordable mass testing of live cattle in the field with results readable in less than 30 minutes. We believe that Vacci-Test BD will provide the required assurance that cattle will soon be able to be exported across any border'' says Bill Hogan, President and CEO.

______

June 14:

Expect upcoming footage from Calgary news conference

______

http://www.vacci-test.com/

6/16/2005 5:35:00 PM

Cattle Alert: World's First Live Cattle Diagnostic Test for BSE

CALGARY, June 16 /CNW/ - Vacci-Test(TM) Corporation today announced that a simple, reliable and economical diagnostic tool for the detection in "live" cattle of infectious Brain Diseases ("BD"), including Bovine Spongiform Encephalopathy (BSE), will soon be available for use on farms and ranches in Canada and around the world.

Designed for the measurement of immunity and the presence of infectious diseases in both humans and animals, patented Vacci-Test(TM) allows for the precise evaluation of the immune status very quickly through a simple blood test. Vacci-Test(TM) BD can determine the presence of a protein marker which identifies brain infections such as BSE in cattle.

"A single drop of blood will identify the presence of Protein 14-3-3, the marker for brain infections, including BSE," says Bill Hogan, President and CEO. "This will facilitate affordable mass testing of live cattle in the field with results readable in less than 30 minutes. Furthermore, Vacci-Test(TM) platform can diagnose any kind of bacteria-viruses based infectious diseases in livestock and humans. To this end, we now have 6 additional Vacci-Test(TM) In Vitro diagnostic products ready for commercialization," said Hogan.

"Vacci-Test(TM) BD represents a significant scientific and medical breakthrough as it has the in-field ability to detect a marker in the blood that is present when an animal or human has an infectious brain symptom, such as BSE in cattle or new variant Creutzfeldt-Jakob Disease in humans," says Dr. Jacques Mayet, co-inventor, who has been working on the procedure platform in Lyon, France since 1996. "The breakthrough for our Vacci-Test(TM) BD came when live BSE sera was made available to us for testing by both the AFFSA of France, and the Veterinary Laboratories Agency (VLA), Weybridge, England that is managed by Danny Matthews," said Mayet.

The Scientific Review of the last 2-years test results has been continuously filed with the French Food Safety Agency (AFSSA), the European Food Commission (EFSA) in Brussels, and the VLA. The Canadian Food Inspection Agency (CFIA), Health Canada and the Alberta Government have also received updated test results. The next step is to transfer all of the final results to EFSA and CFIA. These Agencies will then follow our protocols in order to confirm the internal lab results for Validation. The EFSA in Brussels will then add the test to their approved list. The Validation procedure will allow the test to be used in the market place to guarantee the safety of their cattle. Upon Validation, Vacci-Test(TM): BD can then go to the market, which is expected this fall.

"The implications for the livestock industry are extensive. Soon producers will be able to certify that their cattle are free of brain infections such as BSE. We believe that Vacci-Test(TM) BD will provide the required assurance to allow cattle to be exported across any border," says Hogan.

At present, BSE can only be detected "post-mortem", in a laboratory procedure that takes much longer to identify and is significantly more expensive than the "pre-mortem" Vacci-Test(TM).

"We forecast that Vacci-Test(TM) BD, at a cost of approximately $20 per animal, will be available in North America for purchase by the fall of 2005," says Hogan.

For more information contact: William J. Hogan or The Honourable Charlie Mayer or visit www.vacci-test.com.

http://www.cattlenetwork.com/content.asp?ContentId=5333

World's First Live Cattle Diagnostic Test For BSE Developed In Canada
Jun. 17, 2005

Vacci-TestTM Corporation has announced that a simple, reliable and economical diagnostic tool for the detection of infectious Brain Diseases (BD) in live cattle, which includes Bovine Spongiform Encephalopathy (BSE), will soon be available for use on farms and ranches in Canada and around the world.

Designed for the measurement of immunity and presence of infectious diseases in both humans and animals, patented Vacci-TestTM allows for the precise evaluation of the immune status very quickly through a simple blood test. Vacci-TestTM BD can determine the presence of a protein marker which identifies brain infections such as BSE in cattle.

"With a single drop of blood will identify the presence of Protein 14-3-3, the marker for brain infections, including BSE," says Bill Hogan, President and CEO. "This will facilitate affordable mass testing of live cattle in the field with results readable in less than 30 minutes. What is even more fascinating is that the Vacci-TestTM platform can diagnose any kind of bacteria-viruses based infectious diseases in livestock and humans. To this end, we now have 6 additional Vacci-TestTM In Vitro diagnostic products ready for commercialization," said Hogan.

The Scientific Review of the last 2-years test results have been continuously filed with the French Food Safety Agency (AFSSA), the European Food Commission (EFSA) in Brussels, and the VLA. The Canadian Food Inspection Agency (CFIA), Health Canada and the Alberta Government have received updated test results. The next step is to transfer all of the final results to EFSA and CFIA. These Agencies will then follow our protocols in order to confirm the internal lab results for Validation. The European Agency in Brussels then adds the test to their approved list. The Validation procedure allows the test to be used by the market place to guarantee the safety of their cattle. Upon Validation, Vacci-TestTM BD can then go to the market, which is expected this fall.

"The implications for the livestock industry are extensive. Soon producers will be able to certify that their cattle are free of brain infections such as BSE. We believe that Vacci-TestTM BD will provide the required assurance that cattle will soon be able to be exported across any border," says Hogan.

At present, BSE can only be detected post-mortem, in a laboratory procedure that takes much longer to identify and is significantly more expensive than the pre-mortem Vacci-TestTM.

Source: Company release

http://www.agprofessional.com/show_story.php?id=33430

TSS




Follow Ups:



Post a Followup

Name:
E-mail: (optional)
Subject:

Comments:

Optional Link URL:
Link Title:
Optional Image URL: